Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Oversold

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Jan 20, 2022 9:24am

210 Views

Post# 34336797

Oversold

Tbp is way oversold. Best part this happened ahead of major milestones for the company. They are turning to revenue with Reduvo approval expected the q. As for QIXLEEF that is really the big one once comparison of head to head trial against opioid is released. How much that will worth?? Mc at 50 million is a jock. Hold tight longs

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo